Pompe disease is a rare, chronically debilitating metabolic disorder caused by deficiency of the enzyme acid alpha-glucosidase. As enzyme replacement
Press Release Épalinges, Switzerland, June 1st, 2026 Machine Learning Maps and Discovers Clinical Endpoints in Pompe Disease Using Real-World
Tech Tour Growth Health is one of Europe’s most established gatherings at the intersection of healthcare innovation and investment –
Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor between Lausanne & London, hosted
The idea that an AI system could detect a disease that appears nowhere in a patient’s medical record sounds like
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes research to explore the
